idarubicin has been researched along with Hepatitis B in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakir, T; Bektaş, A; Cakar, B; Turgut, M; Ustaoğlu, M | 1 |
1 other study(ies) available for idarubicin and Hepatitis B
| Article | Year |
|---|---|
Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy.
Topics: Antineoplastic Agents; Cytarabine; Fatal Outcome; Female; Hepatitis B; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Tretinoin; Virus Activation | 2010 |